Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model
about
Recent progress in West Nile virus diagnosis and vaccinationWest Nile Virus in Europe and Safety of Blood TransfusionNewcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultryPlant-made vaccines against West Nile virus are potent, safe, and economically feasibleWest Nile viral infection of equidsDevelopment of replication-competent viral vectors for HIV vaccine delivery.Bioinformatics in new generation flavivirus vaccines.Serological, molecular and entomological surveillance demonstrates widespread circulation of West Nile virus in Turkey.Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus.Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foalsDNA vaccines in veterinary use.Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control.Phenotypic characterisation of cell populations in the brains of horses experimentally infected with West Nile virus.A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.Risk factors for West Nile virus infection and disease in populations and individuals.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyWest Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safetyWest Nile virus state of the art report of MALWEST Project.Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.Innate immune recognition of poxviral vaccine vectors.Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.Immunohistochemistry for the detection of neural and inflammatory cells in equine brain tissue.West Nile virusSurveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity
P2860
Q21284433-D428DCE4-3A94-41E4-90F7-C964BFE1F0BEQ26741185-889196D3-83E6-4AA9-89AE-68AE4A2A7204Q27469028-0F60FAD8-7AD9-4FB4-9B9A-22B04CA90F97Q28082778-95740F2B-9F64-4BAB-9F7C-F8821CAEF147Q30402540-F20A1AF3-D2C4-45CF-B3DE-13D1B1DF3675Q33694226-27B488AF-120F-404D-95A4-1A4E6E162B49Q33839001-55AE44D9-9F50-4779-B1A5-54BFFB1B32EAQ33945548-76A4151B-4274-4B80-AF72-61B69A631668Q34047030-EE8E05C6-2A79-4081-99C9-F5CDAEDF7EDAQ34720701-FEA08057-4F73-4028-A613-4E5297AB8B51Q35586830-4371DE0B-0246-4D28-A657-DE049DF1A38BQ35998781-AE0A4A4A-E9D5-4F8A-B01D-1163767EC2FFQ36096374-4784144A-A670-4BB5-9ADE-D47C061B5A15Q36362733-CB8A1C91-FAE6-4034-817B-0C5E0AAEC099Q36607383-973DA26C-2F5F-4FD8-82F3-1E54C1D27B43Q37082586-101FB14C-C5AF-41F1-B7AE-22C08DD2887DQ37123147-B92F5E83-910E-41BC-8C0B-1A1C8168151CQ37306783-6C155A2E-A847-4EC1-B9E1-6350F4969717Q37434776-111B10A3-0704-4415-ABBD-3C0371375EE5Q37666763-18E3C613-FA80-4330-83D2-2733CA4B11F5Q37842337-B421096F-D253-4DFF-B14C-B367E292E4DAQ37944321-58CFA3B8-17FD-473D-BB9E-D32316B7B349Q38008644-E9B1B12E-9BBB-4647-9E04-0901EF786AEDQ38258362-C3569411-2DED-452B-B00E-5281998798E5Q56932479-9F0A1DA5-38E3-4BE6-A235-2344DFF10237Q58122913-51DEDA8A-422D-4249-A2B0-139E08DEA7EA
P2860
Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@ast
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@en
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@nl
type
label
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@ast
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@en
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@nl
prefLabel
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@ast
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@en
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@nl
P2093
P2860
P3181
P356
P1476
Comparative Efficacies of Thre ...... Equine WNV Encephalitis Model
@en
P2093
E P J Gibbs
M A Bourgeois
P P Humphrey
S E Beachboard
P2860
P304
P3181
P356
10.1128/CVI.00249-07
P577
2007-11-01T00:00:00Z